{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:42:16Z","timestamp":1792734136248,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/jcp.0b013e3182905b77","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T15:27:22Z","timestamp":1371137242000},"page":"528-532","source":"Crossref","is-referenced-by-count":17,"title":["Neurochemical Effects of Quetiapine in Patients With Bipolar Mania"],"prefix":"10.1097","volume":"33","author":[{"given":"Caleb M.","family":"Adler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P.","family":"DelBello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly B.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Welge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rummelhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Strakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1176\/ajp.127.3.345","article-title":"Effectiveness of lithium carbonate in the treatment of manic-depressive illness.","volume":"127","author":"Van der Velde","year":"1970","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-0327(86)90057-1","article-title":"Clinical prediction of outcome and lithium response in bipolar affective disorder.","volume":"11","author":"Mander","year":"1986","journal-title":"J Affect Disord"},{"issue":"3","key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-0327(89)90005-0","article-title":"Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients.","volume":"17","author":"Maj","year":"1989","journal-title":"J Affect Disord"},{"issue":"4","key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/scnp.2002.35226","article-title":"Mood disorders: treatment-induced changes in brain neurochemistry and structure.","volume":"7","author":"Glitz","year":"2002","journal-title":"Semin Clin Neuropsychiatry"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0006-3223(93)90098-X","article-title":"Structural brain abnormalities in first-episode mania.","volume":"33","author":"Strakowski","year":"1993","journal-title":"Biol Psychiatry"},{"issue":"10","key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(02)01911-X","article-title":"Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.","volume":"53","author":"Bertolino","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"6","key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1399-5618.2002.02235.x","article-title":"Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy.","volume":"4","author":"Cecil","year":"2002","journal-title":"Bipolar Disord"},{"issue":"11","key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0006-3223(02)01744-4","article-title":"Decreased N-acetylaspartate in children with familial bipolar disorder.","volume":"53","author":"Chang","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"5","key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","article-title":"Brain metabolic alterations in medication-free patients with bipolar disorder.","volume":"61","author":"Dager","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0893-133X(00)00207-4","article-title":"Decreased anterior cingulate myo-inositolcreatine spectroscopy resonance with lithium treatment in children with bipolar disorder.","volume":"24","author":"Davanzo","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.npp.1300950","article-title":"Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.","volume":"31","author":"DelBello","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hup.671","article-title":"A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.","volume":"20","author":"Frey","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1017\/S0033291799008442","article-title":"Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder.","volume":"29","author":"Hamakawa","year":"1999","journal-title":"Psychol Med"},{"issue":"6","key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-3223(99)00183-3","article-title":"Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder.","volume":"47","author":"Winsberg","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"1","key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0033291706008968","article-title":"Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.","volume":"37","author":"Atmaca","year":"2007","journal-title":"Psychol Med"},{"issue":"1","key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jad.2004.12.008","article-title":"1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.","volume":"86","author":"Brambilla","year":"2005","journal-title":"J Affect Disord"},{"issue":"5","key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2004.06.012","article-title":"Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.","volume":"56","author":"Friedman","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"1","key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0920-9964(92)90059-E","article-title":"Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients.","volume":"8","author":"Sharma","year":"1992","journal-title":"Schizophr Res"},{"issue":"2","key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-200303000-00002","article-title":"Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.","volume":"18","author":"Silverstone","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.pnpbp.2007.04.009","article-title":"Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy.","volume":"31","author":"Kim","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/cap.2007.151","article-title":"Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.","volume":"18","author":"Patel","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1399-5618.2012.01022.x","article-title":"The functional neuroanatomy of bipolar disorder: a consensus model.","volume":"14","author":"Strakowski","year":"2012","journal-title":"Bipolar Disord"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G","article-title":"In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time.","volume":"41","author":"Tkac","year":"1999","journal-title":"Magn Reson Med"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentration from localized in vivo proton NMR spectra.","volume":"30","author":"Provincher","year":"1993","journal-title":"Magn Reson Med"},{"issue":"5","key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mrm.1910320504","article-title":"Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T.","volume":"32","author":"Hetherington","year":"1994","journal-title":"Magn Reson Med"},{"issue":"6","key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1399-5618.2005.00266.x","article-title":"N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder.","volume":"7","author":"Gallelli","year":"2005","journal-title":"Bipolar Disord"},{"issue":"6","key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11920-004-0012-1","article-title":"Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.","volume":"6","author":"Delbello","year":"2004","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1176\/appi.ajp.160.5.873","article-title":"Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.","volume":"160","author":"Deicken","year":"2003","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182905b77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:34Z","timestamp":1620957694000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201308000-00013"}},"subtitle":["A Proton Magnetic Resonance Spectroscopy Study"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182905b77","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}